Last Updated: November 13, 2026

Details for New Drug Application (NDA): 204730

« Back to Dashboard

NDA 204730 describes FROVATRIPTAN SUCCINATE, which is a drug marketed by Amneal Pharms Co, Glenmark Pharms Ltd, Leading, Pharmobedient, and Renata, and is included in five NDAs. It is available from four suppliers. Additional details are available on the FROVATRIPTAN SUCCINATE profile page.

The generic ingredient in FROVATRIPTAN SUCCINATE is frovatriptan succinate. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.

Summary for 204730

Tradename:	FROVATRIPTAN SUCCINATE
Applicant:	Glenmark Pharms Ltd
Ingredient:	frovatriptan succinate
Patents:	0

Pharmacology for NDA: 204730

Mechanism of Action	Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists

Suppliers and Packaging for NDA: 204730

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
FROVATRIPTAN SUCCINATE	frovatriptan succinate	TABLET;ORAL	204730	ANDA	Glenmark Pharmaceuticals Inc., USA	68462-694	68462-694-97	1 BLISTER PACK in 1 CARTON (68462-694-97) / 9 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 2.5MG BASE
Approval Date:	Mar 11, 2016	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.